Literature DB >> 10692150

Lipopolysaccharide core phosphates are required for viability and intrinsic drug resistance in Pseudomonas aeruginosa.

A G Walsh1, M J Matewish, L L Burrows, M A Monteiro, M B Perry, J S Lam.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen that is notorious for its intrinsic drug resistance. We have used chemical and genetic techniques to characterize three putative kinase genes that are involved in the addition of phosphate to the inner core region of P. aeruginosa lipopolysaccharide. The first gene is a waaP homologue, whereas the other two (wapP and wapQ) are unique to P. aeruginosa. Repeated attempts using a variety of membrane-stabilizing conditions to generate waaP:Gm (Gm, gentamicin) or wapP:Gm mutants were unsuccessful. We were able to generate a chromosomal waaP mutant that had a wild-type copy of either waaPPa or waaPEc in trans, but were unable to cure this plasmid-borne copy of the gene. These results are consistent with the fact that P. aeruginosa mutants lacking inner core heptose (Hep) or phosphate have never been isolated and demonstrate the requirement of Hep-linked phosphate for P. aeruginosa viability. A wapQ:Gm mutant was isolated and it had an unaltered minimum inhibitory concentration (MIC) for novobiocin and only a small decrease in the MIC for sodium dodecyl sulphate (SDS), suggesting that the loss of a phosphate group transferred by WapQ may only be having a small impact on outer-membrane permeability. Nuclear magnetic resonance and methylation linkage analysis showed that WaaPPa could add one phosphate to O4 of HepI in a Salmonella typhimurium waaP mutant. The expression of WaaPPa increased the outer-membrane integrity of these complemented mutants, as evidenced by 35-fold and 75-fold increases in the MIC for novobiocin and SDS respectively. The S. typhimurium waaP mutant transformed with both waaP and wapP had over 250-fold and 1000-fold increases, respectively, in these MICs. The inner core phosphates of P. aeruginosa appear to be playing a key role in the intrinsic drug resistance of this bacterium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692150     DOI: 10.1046/j.1365-2958.2000.01741.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  36 in total

1.  Nonradiolabeling assay for WaaP, an essential sugar kinase involved in biosynthesis of core lipopolysaccharide of Pseudomonas aeruginosa.

Authors:  Xin Zhao; Cory Q Wenzel; Joseph S Lam
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 2.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

3.  Pseudomonas aeruginosa possesses two putative type I signal peptidases, LepB and PA1303, each with distinct roles in physiology and virulence.

Authors:  Richard D Waite; Ruth S Rose; Minnie Rangarajan; Joseph Aduse-Opoku; Ahmed Hashim; Michael A Curtis
Journal:  J Bacteriol       Date:  2012-06-22       Impact factor: 3.490

Review 4.  Microbial protein-tyrosine kinases.

Authors:  Joseph D Chao; Dennis Wong; Yossef Av-Gay
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

5.  Weakening effect of cell permeabilizers on gram-negative bacteria causing biodeterioration.

Authors:  H-L Alakomi; A Paananen; M-L Suihko; I M Helander; M Saarela
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

6.  Use of in-biofilm expression technology to identify genes involved in Pseudomonas aeruginosa biofilm development.

Authors:  Antonio Finelli; Claude V Gallant; Keith Jarvi; Lori L Burrows
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

7.  Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin.

Authors:  Michelle D Brazas; Elena B M Breidenstein; Joerg Overhage; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2007-09-24       Impact factor: 5.191

8.  Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant.

Authors:  Nicole R Luke; Simon Allen; Bradford W Gibson; Anthony A Campagnari
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  Characterization of the lipopolysaccharide from a wbjE mutant of the serogroup O11 Pseudomonas aeruginosa strain, PA103.

Authors:  Biswa Choudhury; Russell W Carlson; Joanna B Goldberg
Journal:  Carbohydr Res       Date:  2007-11-07       Impact factor: 2.104

10.  SoxRS-mediated lipopolysaccharide modification enhances resistance against multiple drugs in Escherichia coli.

Authors:  Joon-Hee Lee; Kang-Lok Lee; Won-Sik Yeo; Su-Jin Park; Jung-Hye Roe
Journal:  J Bacteriol       Date:  2009-04-17       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.